Investors in GeneDx Holdings Corp. with substantial losses may have the chance to join a class action lawsuit, according to recent PR Newswire report.

• The Light Hub Team
• July 7, 2026

Ademi LLP is investigating whether Crinetics Pharmaceuticals is obtaining a fair price for shareholders, raising questions about potential undervaluation or misconduct.

• The Light Hub Team
• July 7, 2026

The S&P 500’s cyclically adjusted price-to-earnings ratio has reached a level only seen during the dot-com bubble, raising concerns among investors.

• The Light Hub Team
• July 6, 2026